medigraphic.com
Anales de Otorrinolaringología Mexicana

2024, Number 3

<< Back

Otorrinolaringología 2024; 69 (3)

Tracheal mucosa melanoma: A rare diagnosis in an unusual site

Barrón SMA, Barrón CAC, Campos NLA, Pérez CJA

Language: Spanish
References: 18
Page: 218-224
PDF size: 556.67 Kb.


ABSTRACT

Background: Melanoma is a malignant lesion with aggressive behavior, with a rapid evolutionary process that may cause melanic and amelanic lesions, particularly in the mucosa.
Clinical case: A 48-year-old male patient initially diagnosed as an asthmatic process and, given the poor response to treatment, he was sent to Otorhinolaryngology service, where a tracheal neoformation with a histopathological report of melanoma was confirmed.
Conclusions: The early identification of melanoma allows to offer the patient and clinician care choices and damage limitation.


REFERENCES

  1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneousmelanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commissionon Cancer and the American Cancer Society. Cancer 1998; 83 (8): 1664-78. doi: 10.1002/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g

  2. Guy GP Jr, Thomas CC, Thompson T, Watson M, et al. Centers for Disease Control and Prevention (CDC).Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWRMorb Mortal Wkly Rep 2015; 64 (21): 591-6.

  3. Tomicic J, Wanebo HJ. Mucosal melanomas. Surg Clin North Am 2003; 83 (2): 237-52. doi: 10.1016/S0039-6109(02)00100-7

  4. Spadafora M, Santandrea G, Lai M, et al. Clinical review of mucosal melanoma. The 11 year experience ofa referral center. Dermatol Pract Concept 2023; 13 (1): e2023057. Doi:https://doi.org/10.5826/dpc.1301a57

  5. Papaspyrou G, Garbe C, Schadendorf D, et al. Mucosal melanomas of the head and neck: new aspects ofthe clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res 2011; 21 (6):475-82. doi: 10.1097/CMR.0b013e32834b58cf

  6. Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol 2007; 56 (5): 828-34.doi: 10.1016/j.jaad.2006.06.017

  7. Elder DE, Bastian BC, Cree IA, Massi D, et al. World Health Organization 2018 Classification of Cutaneous,Mucosal and Uveal Melanoma: Detailed analysis of 9 distinct subtypes defined by their pathway. ArchPathol Lab Med 2020; 144 (4): 500-522. doi: https://doi.org/10.5858/arpa.2019-0561-RA

  8. Spencer KR, Mehnert JM. Mucosal melanoma: Epidemiology, biology and treatment. Cancer Treat Res 2016;167: 295-320. doi: 10.1007/978-3-319-22539-5_13

  9. Mao L, Qi Z, Zhang L, Guo J, Si L. Immunotherapy in acral and mucosal melanoma: Current status andfuture directions. Front Immunol 2021; 12: 680407. doi: 10.3389/fimmu.2021.680407

  10. Bachar G, Loh KS, O’Sullivan B, Goldstein D, et al. Mucosal melanomas of the head and neck: experienceof the Princess Margaret Hospital. Head Neck 2008; 30 (10): 1325-31. doi: 10.1002/hed.20878

  11. Kempele AA, Azarjana KB, Cema IC, Rivosh AD, et al. Cutaneous and mucosa head and neck melanoma.Melanoma Res 2010; e47-e48. DOI: 10.1097/01.cmr.0000382841.53523.1b

  12. Serman N, Vranic S, Glibo M, Serman L, et al. Genetic risk factors in melanoma etiopathogenesis andthe role of genetic counseling: A concise review. Bosn J Basic Med Sci 2022; 22 (5): 673-682. doi: 10.17305/bjbms.2021.7378

  13. Bobos M. Histopathologic classification and prognostic factors of melanoma: a 2021 update. Ital J DermatolVenerol 2021; 156 (3): 300-321. doi: 10.23736/S2784-8671.21.06958-3

  14. Garbe C, Amaral T, Peris K, Hauschild A, et al; European Dermatology Forum (EDF), the European Associationof Dermato-Oncology (EADO), and the European Organization for Research and Treatment ofCancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics- Update 2019.

  15. Mısır AF, Durmuşlar MC, Zerener T, Gün BD. Primary malignant melanoma. Saudi Med J 2016; 37 (4):446-9. doi: 10.15537/smj.2016.4.15017

  16. Gavriel H, McArthur G, Sizeland A, Henderson M. Review: mucosal melanoma of the head and neck. MelanomaRes 2011; 21 (4): 257-66. doi: 10.1097/CMR.0b013e3283470ffd

  17. Jung S, Johnson DB. Management of acral and mucosal melanoma: medical oncology perspective. Oncologist2022; 27 (8): 703-710. doi: 10.1093/oncolo/oyac091

  18. Cabrera R, Recule F. Unusual clinical presentations of malignant melanoma: A review of clinical and histologicfeatures with special emphasis on dermatoscopic findings. Am J Clin Dermatol 2018; Supl 1: 15-23.doi: 10.1007/s40257-018-0373-6




2020     |     www.medigraphic.com